Plain-English translation of NCT07507643 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether , a steroid medication, can help reduce complications after major liver surgery. Researchers will give some patients the medication before surgery and compare their recovery to patients who receive standard care without it. The goal is to see if this treatment can lower infection rates and help people go home from the hospital sooner.
Major liver surgery can be hard on the body and sometimes leads to serious infections or longer hospital stays. Doctors want to know if giving this medication before surgery can protect patients and improve their recovery.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the steroid medication or standard care before your scheduled liver surgery. You will receive your assigned treatment, then have your surgery as planned. The research team will then monitor your recovery in the hospital and track whether you develop infections or other complications, comparing outcomes between the two groups.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
United States